Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer (Q34155977)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer |
scientific article |
Statements
1 reference
Discovery and SAR of 5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid (CX-4945), the first clinical stage inhibitor of protein kinase CK2 for the treatment of cancer (English)
1 reference
Fabrice Pierre
1 reference
Peter C Chua
1 reference
Sean E O'Brien
1 reference
Adam Siddiqui-Jain
1 reference
Pauline Bourbon
1 reference
Mustapha Haddach
1 reference
Jerome Michaux
1 reference
Johnny Nagasawa
1 reference
Michael K Schwaebe
1 reference
Eric Stefan
1 reference
Anne Vialettes
1 reference
Jeffrey P Whitten
1 reference
Ta Kung Chen
1 reference
Levan Darjania
1 reference
Ryan Stansfield
1 reference
Kenna Anderes
1 reference
Josh Bliesath
1 reference
Denis Drygin
1 reference
Caroline Ho
1 reference
May Omori
1 reference
Chris Proffitt
1 reference
Nicole Streiner
1 reference
Katy Trent
1 reference
William G Rice
1 reference
David M Ryckman
1 reference
21 December 2010
1 reference
1 reference
Identifiers
1 reference